Maternal low-dose estradiol-17β exposure during pregnancy impairs postnatal progeny weight development and body composition

Toxicology and Applied Pharmacology

Volumn 263, Issue 3, 2012, Pages 338-344

  Werner Fürst, Rainer ^a   Pistek, Veronika Leopoldine ^a   Kliem, Heike ^a   Skurk, Thomas ^a,b   Hauner, Hans ^a,b   Meyer, Heinrich Herman Dietrich ^a   Ulbrich, Susanne Ernestine ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Birth weight; Childhood disease; Endocrine disruptors; Epigenetics; Estradiol 17 ; Fetal basis of adult disease; Obesity

Indexed keywords

ESTRADIOL; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; BIRTH WEIGHT; BODY COMPOSITION; BODY FAT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; ESTRADIOL BLOOD LEVEL; FEMALE; LOW DRUG DOSE; MALE; NONHUMAN; POSTNATAL DEVELOPMENT; PREGNANCY; PRENATAL EXPOSURE; PROGENY; SOW (SWINE); TESTOSTERONE BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ESTRADIOL; ESTROGENS; FEMALE; IMMUNOENZYME TECHNIQUES; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEX FACTORS; SWINE;

SUIDAE;

EID: 84865430575     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.07.006     Document Type: Article

References (61)

1. Ailhaud G., Grimaldi P., Negrel R. Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr. 1992, 12:207-233.
2. Akingbemi B.T., Sottas C.M., Koulova A.I., Klinefelter G.R., Hardy M.P. Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology 2004, 145:592-603.
3. Akishita M., Fukai S., Hashimoto M., Kameyama Y., Nomura K., Nakamura T., Ogawa S., Iijima K., Eto M., Ouchi Y. Association of low testosterone with metabolic syndrome and its components in middle-aged Japanese men. Hypertens. Res. 2010, 33:587-591.
4. Bauer J., Heinritzi K., Gareis M., Gedek B. Changes in the genital tract of female swine after feeding with practice-relevant amounts of zearalenone. Tierarztl. Prax. 1987, 15:33-36.
5. Bjorntorp P. Hormonal control of regional fat distribution. Hum. Reprod. 1997, 12(Suppl. 1):21-25.
6. Blottner S., Hingst O., Meyer H.H. Inverse relationship between testicular proliferation and apoptosis in mammalian seasonal breeders. Theriogenology 1995, 44:321-328.
7. Brienne J.P., Denoyelle C., Baussart H., Daudin J.D. Assessment of meat fat content using dual energy X-ray absorption. Meat Sci. 2001, 57:235-244.
8. Cardone A., Angelini F., Varriale B. Autoregulation of estrogen and androgen receptor mRNAs and downregulation of androgen receptor mRNA by estrogen in primary cultures of lizard testis cells. Gen. Comp. Endocrinol. 1998, 110:227-236.
9. Catenacci V.A., Hill J.O., Wyatt H.R. The obesity epidemic. Clin. Chest Med. 2009, 30:415-444. (vii).
10. Cederroth C.R., Vinciguerra M., Kuhne F., Madani R., Doerge D.R., Visser T.J., Foti M., Rohner-Jeanrenaud F., Vassalli J.D., Nef S. A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice. Environ. Health Perspect. 2007, 115:1467-1473.
11. Claus R., Haussler S., Lacorn M. Rise of testosterone, nortestosterone, and 17beta-estradiol concentrations in peripheral blood plasma of pigs after sublingual application in vivo. Food Chem. Toxicol. 2007, 45:225-228.
12. Coelingh Bennink H.J. Are all estrogens the same?. Maturitas 2004, 47:269-275.
13. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 1993, 101:378-384.
14. Daxenberger A., Lange I.G., Meyer K., Meyer H.H. Detection of anabolic residues in misplaced implantation sites in cattle. J. AOAC Int. 2000, 83:809-819.
15. Demir B., Ozturkoglu E., Solaroglu A., Baskan B., Kandemir O., Karabulut E., Haberal A. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women. Gynecol. Endocrinol. 2008, 24:347-353.
16. Dieudonne M.N., Pecquery R., Leneveu M.C., Giudicelli Y. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 2000, 141:649-656.
17. Gioiosa L., Fissore E., Ghirardelli G., Parmigiani S., Palanza P. Developmental exposure to low-dose estrogenic endocrine disruptors alters sex differences in exploration and emotional responses in mice. Horm. Behav. 2007, 52:307-316.
18. Gluckman P.D., Hanson M.A. Living with the past: evolution, development, and patterns of disease. Science 2004, 305:1733-1736.
19. Grun F., Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev. Endocr. Metab. Disord. 2007, 8:161-171.
20. Haeussler S., Wagner A., Welter H., Claus R. Changes of testicular aromatase expression during fetal development in male pigs (Sus scrofa). Reproduction 2007, 133:323-330.
21. Heindel J.J., vom Saal F.S. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol. Cell. Endocrinol. 2009, 304:90-96.
22. Ho S.M., Tang W.Y., Belmonte de Frausto J., Prins G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 2006, 66:5624-5632.
23. Janesick A., Blumberg B. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res. C Embryo Today 2011, 93:34-50.
24. JECFA Fifty-third meeting Rome, 1-10 June 1999. Summary and conclusions 1999, Joint FAO/WHO Expert Committee on Food Additives, Rome.
25. Kirchner S., Kieu T., Chow C., Casey S., Blumberg B. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol. Endocrinol. 2010, 24:526-539.
26. Kortenkamp A. Introduction: endocrine disruptors-exposure assessment, novel end points, and low-dose and mixture effects. Environ. Health Perspect. 2007, 115(Suppl. 1):7.
27. Kortenkamp A. Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. Int. J. Androl. 2008, 31:233-240.
28. Krishnan A.V., Stathis P., Permuth S.F., Tokes L., Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993, 132:2279-2286.
29. Marcoux M., Bernier J.F., Pomar C. Estimation of Canadian and European lean yields and composition of pig carcasses by dual-energy X-ray absorptiometry. Meat Sci. 2003, 63:359-365.
30. Meyer H.H., Sauerwein H., Mutayoba B.M. Immunoaffinity chromatography and a biotin-streptavidin amplified enzymeimmunoassay for sensitive and specific estimation of estradiol-17 beta. J. Steroid Biochem. 1990, 35:263-269.
31. Misso M.L., Murata Y., Boon W.C., Jones M.E., Britt K.L., Simpson E.R. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology 2003, 144:1474-1480.
32. Miyawaki J., Sakayama K., Kato H., Yamamoto H., Masuno H. Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J. Atheroscler. Thromb. 2007, 14:245-252.
33. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.G., Boechler M., Welshons W.V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect. 1997, 105:70-76.
34. Newbold R.R., Padilla-Banks E., Snyder R.J., Jefferson W.N. Developmental exposure to estrogenic compounds and obesity. Birth Defects Res. A Clin. Mol. Teratol. 2005, 73:478-480.
35. Newbold R.R., Padilla-Banks E., Snyder R.J., Jefferson W.N. Perinatal exposure to environmental estrogens and the development of obesity. Mol. Nutr. Food Res. 2007, 51:912-917.
36. Newbold R.R., Padilla-Banks E., Jefferson W.N., Heindel J.J. Effects of endocrine disruptors on obesity. Int. J. Androl. 2008, 31:201-208.
37. Newbold R.R., Padilla-Banks E., Jefferson W.N. Environmental estrogens and obesity. Mol. Cell. Endocrinol. 2009, 304:84-89.
38. Raghuveer G. Lifetime cardiovascular risk of childhood obesity. Am. J. Clin. Nutr. 2010, 91:1514S-1519S.
39. Raj M., Kumar R.K. Obesity in children & adolescents. Indian J. Med. Res. 2010, 132:598-607.
40. Reilly J.J. Descriptive epidemiology and health consequences of childhood obesity. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19:327-341.
41. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 2006, 7:885-896.
42. Rubin B.S., Murray M.K., Damassa D.A., King J.C., Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. 2001, 109:675-680.
43. Ruhlen R.L., Howdeshell K.L., Mao J., Taylor J.A., Bronson F.H., Newbold R.R., Welshons W.V., vom Saal F.S. Low phytoestrogen levels in feed increase fetal serum estradiol resulting in the "fetal estrogenization syndrome" and obesity in CD-1 mice. Environ. Health Perspect. 2008, 116:322-328.
44. Schneweis I., Meyer K., Engelhardt G., Bauer J. Occurrence of zearalenone-4-beta-d-glucopyranoside in wheat. J. Agric. Food Chem. 2002, 50:1736-1738.
45. Schwarzenberger F., Toole G.S., Christie H.L., Raeside J.I. Plasma levels of several androgens and estrogens from birth to puberty in male domestic pigs. Acta Endocrinol. (Copenh.) 1993, 128:173-177.
46. Semirale A.A., Zhang X.W., Wiren K.M. Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation. J. Cell. Biochem. 2011, 112:1773-1786.
47. Simpson E.R., MacDonald P.C. Endocrine physiology of the placenta. Annu. Rev. Physiol. 1981, 43:163-188.
48. Singh R., Artaza J.N., Taylor W.E., Gonzalez-Cadavid N.F., Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 2003, 144:5081-5088.
49. Skakkebaek N.E., Rajpert-De Meyts E., Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 2001, 16:972-978.
50. Somm E., Schwitzgebel V.M., Toulotte A., Cederroth C.R., Combescure C., Nef S., Aubert M.L., Huppi P.S. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ. Health Perspect. 2009, 117:1549-1555.
51. Speakman J.R., Booles D., Butterwick R. Validation of dual energy X-ray absorptiometry (DXA) by comparison with chemical analysis of dogs and cats. Int. J. Obes. Relat. Metab. Disord. 2001, 25:439-447.
52. Stubbins R.E., Holcomb V.B., Hong J., Nunez N.P. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur. J. Nutr. 2011, 10.1007/s00394-011-0266-4.
53. Swan S.H., Liu F., Overstreet J.W., Brazil C., Skakkebaek N.E. Semen quality of fertile US males in relation to their mothers' beef consumption during pregnancy. Hum. Reprod. 2007, 22:1497-1502.
54. Szyf M. The early life environment and the epigenome. Biochim. Biophys. Acta 2009, 1790:878-885.
55. The N.S., Suchindran C., North K.E., Popkin B.M., Gordon-Larsen P. Association of adolescent obesity with risk of severe obesity in adulthood. JAMA 2010, 304:2042-2047.
56. Thijssen S., Maringwa J., Faes C., Lambrichts I., Van Kerkhove E. Chronic exposure of mice to environmentally relevant, low doses of cadmium leads to early renal damage, not predicted by blood or urine cadmium levels. Toxicology 2007, 229:145-156.
57. Timms B.G., Howdeshell K.L., Barton L., Bradley S., Richter C.A., vom Saal F.S. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7014-7019.
58. vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., Dhar M.D., Ganjam V.K., Parmigiani S., Welshons W.V. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:2056-2061.
59. vom Saal F.S., Nagel S.C., Coe B.L., Angle B.M., Taylor J.A. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol. Cell. Endocrinol. 2012, 354(1-2):74-84.
60. Wagner A., Claus R. Aromatase and 11beta-hydroxysteroid dehydrogenase 2 localisation in the testes of pigs from birth to puberty linked to changes of hormone pattern and testicular morphology. Reprod. Fertil. Dev. 2008, 20:505-512.
61. Welshons W.V., Thayer K.A., Judy B.M., Taylor J.A., Curran E.M., vom Saal F.S. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect. 2003, 111:994-1006.